tirzepatide phase 3 trial study after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 A new study shows that – Tirzepatide for Obesity Treatment and

Type 1 or type 2 errors in studies of TSPO-binding PET radioligand uptake in brain could potentially be explained by the following methodological confounds: Standard neuroimaging techniques were not designed for brainstem study The first-generation radioligand PK11195 has high non-specific binding and low signal-to-background ratio PET signal calculated with an anatomical reference brain region relies on equal radioligand uptake in that region across cases and controls Radioligand access to brain is modified by general metabolism, which can differ across cases and controls Activated peripheral immune cells bind radioligand and can differ in quantity across cases and controls A single nucleotide polymorphism (SNP) in the TSPO gene causes differential radioligand binding Use of healthy controls harms discriminant validity Here, we will address each of these issues and describe solutions

Berezowski, R

Ozempic and Trulicity work in the same way to treat diabetes and lower your risk of certain heart problems

Sloop, K.W

Rigorous Quality Control: Manufactured in a state-of-the-art, quality-controlled facility ensuring optimal purity, free from heavy metals or structural degradation